Literature DB >> 33585286

The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies.

Sydney Newsom1, Hari Priya Parameshwaran1, Lindsie Martin1, Rakhi Rajan1.   

Abstract

Bacterial and archaeal CRISPR-Cas systems offer adaptive immune protection against foreign mobile genetic elements (MGEs). This function is regulated by sequence specific binding of CRISPR RNA (crRNA) to target DNA/RNA, with an additional requirement of a flanking DNA motif called the protospacer adjacent motif (PAM) in certain CRISPR systems. In this review, we discuss how the same fundamental mechanism of RNA-DNA and/or RNA-RNA complementarity is utilized by bacteria to regulate two distinct functions: to ward off intruding genetic materials and to modulate diverse physiological functions. The best documented examples of alternate functions are bacterial virulence, biofilm formation, adherence, programmed cell death, and quorum sensing. While extensive complementarity between the crRNA and the targeted DNA and/or RNA seems to constitute an efficient phage protection system, partial complementarity seems to be the key for several of the characterized alternate functions. Cas proteins are also involved in sequence-specific and non-specific RNA cleavage and control of transcriptional regulator expression, the mechanisms of which are still elusive. Over the past decade, the mechanisms of RNA-guided targeting and auxiliary functions of several Cas proteins have been transformed into powerful gene editing and biotechnological tools. We provide a synopsis of CRISPR technologies in this review. Even with the abundant mechanistic insights and biotechnology tools that are currently available, the discovery of new and diverse CRISPR types holds promise for future technological innovations, which will pave the way for precision genome medicine.
Copyright © 2021 Newsom, Parameshwaran, Martin and Rajan.

Entities:  

Keywords:  Cas12a; Cas9; adaptive immunity; bacterial pathogenesis; cascade; clustered regularly interspaced short palindromic repeats and clustered regularly interspaced short palindromic repeat-associated (CRISPR-Cas); gene editing; gene regulation

Year:  2021        PMID: 33585286      PMCID: PMC7876343          DOI: 10.3389/fcimb.2020.619763

Source DB:  PubMed          Journal:  Front Cell Infect Microbiol        ISSN: 2235-2988            Impact factor:   5.293


  118 in total

1.  Identification of genes that are associated with DNA repeats in prokaryotes.

Authors:  Ruud Jansen; Jan D A van Embden; Wim Gaastra; Leo M Schouls
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

2.  A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems.

Authors:  Migle Kazlauskiene; Georgij Kostiuk; Česlovas Venclovas; Gintautas Tamulaitis; Virginijus Siksnys
Journal:  Science       Date:  2017-06-29       Impact factor: 47.728

3.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

Review 4.  The next generation of CRISPR-Cas technologies and applications.

Authors:  Adrian Pickar-Oliver; Charles A Gersbach
Journal:  Nat Rev Mol Cell Biol       Date:  2019-08       Impact factor: 94.444

5.  Catalytically Active Cas9 Mediates Transcriptional Interference to Facilitate Bacterial Virulence.

Authors:  Hannah K Ratner; Andrés Escalera-Maurer; Anaïs Le Rhun; Siddharth Jaggavarapu; Jessie E Wozniak; Emily K Crispell; Emmanuelle Charpentier; David S Weiss
Journal:  Mol Cell       Date:  2019-06-27       Impact factor: 17.970

6.  RNA-activated DNA cleavage by the Type III-B CRISPR-Cas effector complex.

Authors:  Michael A Estrella; Fang-Ting Kuo; Scott Bailey
Journal:  Genes Dev       Date:  2016-02-04       Impact factor: 11.361

7.  DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A.

Authors:  Yung-Hsin Huang; Jianzhong Su; Yong Lei; Lorenzo Brunetti; Michael C Gundry; Xiaotian Zhang; Mira Jeong; Wei Li; Margaret A Goodell
Journal:  Genome Biol       Date:  2017-09-18       Impact factor: 13.583

8.  CRISPR-Cas12a-Assisted Recombineering in Bacteria.

Authors:  Mei-Yi Yan; Hai-Qin Yan; Gai-Xian Ren; Ju-Ping Zhao; Xiao-Peng Guo; Yi-Cheng Sun
Journal:  Appl Environ Microbiol       Date:  2017-08-17       Impact factor: 4.792

9.  RNA-guided gene activation by CRISPR-Cas9-based transcription factors.

Authors:  Pablo Perez-Pinera; D Dewran Kocak; Christopher M Vockley; Andrew F Adler; Ami M Kabadi; Lauren R Polstein; Pratiksha I Thakore; Katherine A Glass; David G Ousterout; Kam W Leong; Farshid Guilak; Gregory E Crawford; Timothy E Reddy; Charles A Gersbach
Journal:  Nat Methods       Date:  2013-07-25       Impact factor: 28.547

10.  High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects.

Authors:  Benjamin P Kleinstiver; Vikram Pattanayak; Michelle S Prew; Shengdar Q Tsai; Nhu T Nguyen; Zongli Zheng; J Keith Joung
Journal:  Nature       Date:  2016-01-06       Impact factor: 49.962

View more
  8 in total

Review 1.  CRISPR-Cas systems: role in cellular processes beyond adaptive immunity.

Authors:  Veena Devi; Kusum Harjai; Sanjay Chhibber
Journal:  Folia Microbiol (Praha)       Date:  2022-07-19       Impact factor: 2.629

2.  Photoactivatable nanoCRISPR/Cas9 System Based on crRNA Reversibly Immobilized on Carbon Nanoparticles.

Authors:  Olga Semikolenova; Lubov Sakovina; Elizaveta Akhmetova; Daria Kim; Ivan Vokhtantsev; Victor Golyshev; Mariya Vorobyeva; Sergey Novopashin; Darya Novopashina
Journal:  Int J Mol Sci       Date:  2021-10-09       Impact factor: 5.923

Review 3.  Digging into the lesser-known aspects of CRISPR biology.

Authors:  Noemí M Guzmán; Belén Esquerra-Ruvira; Francisco J M Mojica
Journal:  Int Microbiol       Date:  2021-09-06       Impact factor: 2.479

Review 4.  The Spread of Antibiotic Resistance Genes In Vivo Model.

Authors:  Shuan Tao; Huimin Chen; Na Li; Tong Wang; Wei Liang
Journal:  Can J Infect Dis Med Microbiol       Date:  2022-07-18       Impact factor: 2.585

Review 5.  Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders.

Authors:  Laura M De Plano; Giovanna Calabrese; Sabrina Conoci; Salvatore P P Guglielmino; Salvatore Oddo; Antonella Caccamo
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

6.  Comparative genomics of Nocardia seriolae reveals recent importation and subsequent widespread dissemination in mariculture farms in the South Central Coast region, Vietnam.

Authors:  Cuong T Le; Erin P Price; Derek S Sarovich; Thu T A Nguyen; Daniel Powell; Hung Vu-Khac; D İpek Kurtböke; Wayne Knibb; Shih-Chu Chen; Mohammad Katouli
Journal:  Microb Genom       Date:  2022-07

Review 7.  Advances in Editing Silkworms (Bombyx mori) Genome by Using the CRISPR-Cas System.

Authors:  Gabriela-Maria Baci; Alexandra-Antonia Cucu; Alexandru-Ioan Giurgiu; Adriana-Sebastiana Muscă; Lilla Bagameri; Adela Ramona Moise; Otilia Bobiș; Attila Cristian Rațiu; Daniel Severus Dezmirean
Journal:  Insects       Date:  2021-12-27       Impact factor: 2.769

8.  A Comparative Analysis of Weizmannia coagulans Genomes Unravels the Genetic Potential for Biotechnological Applications.

Authors:  Martina Aulitto; Laura Martinez-Alvarez; Gabriella Fiorentino; Danila Limauro; Xu Peng; Patrizia Contursi
Journal:  Int J Mol Sci       Date:  2022-03-15       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.